董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Zhou Pengwu Non-executive Co-chairman of the Board 69 未披露 884.78 2024-04-25
Zhang Chen Executive Co-chairman of the Board 38 未披露 未持股 2024-04-25
Wu Binhua Director 42 未披露 未持股 2024-04-25
Laurena Wu Director 40 未披露 2774.59 2024-04-25
Wu Binqi Director 38 未披露 未持股 2024-04-25
Zhang Changsuo Director 43 未披露 未持股 2024-04-25
Zhou Xichun Director 27 未披露 64.26 2024-04-25
Liu Bo Director 53 未披露 未持股 2024-04-25
Lin Yingzhou Independent Director 65 未披露 未持股 2024-04-25
Li Yanyun Independent Director 43 未披露 未持股 2024-04-25
Xu Tianqing Independent Director 28 未披露 未持股 2024-04-25

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Wu Guanhua Chief Financial Officer 42 未披露 148.95 2024-04-25
Hu Qing Chief Operating Officer 61 未披露 114.30 2024-04-25
Zhang Chen Executive Co-chairman of the Board 38 未披露 未持股 2024-04-25

董事简历

中英对照 |  中文 |  英文
Zhou Pengwu

Zhou Pengwu,Aesthetic Medical International Holdings Group Limited创始人之一,Aesthetic Medical International Holdings Group Limited董事会主席兼首席执行官。他自1991年以来一直是一名注册整形外科医生。他拥有30多年的美容医学经验和20多年的美容医院管理经验,从1997年在深圳建立深圳鹏城诊所开始,后来成为鹏城门诊部,然后是深圳鹏城总医院,最后是鹏城医院。他在Aesthetic Medical International Holdings Group Limited担任过各种领导职务,包括鹏城医院和深圳鹏爱医院的总经理和医院行政人员,以及深圳鹏爱医院投资管理有限公司或深圳鹏爱投资的董事长兼总经理。他目前还担任宜春大学美容医学院的兼职教授。2012年当选深圳市企业家协会副会长。2015年当选为中国美容外科协会互联网美容医学分会第一届理事会副主席。现任广东省医学会美容医疗分会第五届理事会副理事长、中国美容外科协会民营美容医疗机构第二届理事会副理事长。2011年参加国家卫生和计划生育委员会关于制定美容医疗机构标准的起草研讨会。他于2005年10月获得北京大学医院管理EMBA学位。被中国国际贸易促进委员会、中国经济导报、中国商业协会(北京)企业家商业俱乐部授予“2017年行业领袖奖”。Zhou博士是Aesthetic Medical International Holdings Group Limited副主席Ding女士的现任配偶,也是Aesthetic Medical International Holdings Group Limited董事Zhou Yitao博士的父亲。


Zhou Pengwu,is one of Aesthetic Medical International Holdings Group Limited founders and is Aesthetic Medical International Holdings Group Limited non-executive co-chairman of the board of directors. Dr. Zhou has been a registered plastic surgeon since 1991. He has over 30 years of experience in aesthetic medicine and over 20 years of experience in managing aesthetic medical hospitals, beginning with the establishment of the Shenzhen Pengcheng Clinic in Shenzhen in 1997, which later became the Pengcheng Outpatient Department, then the Shenzhen Pengcheng General Hospital, and finally the Pengcheng Hospital. He acted in a variety of leadership positions in Aesthetic Medical International Holdings Group Limited company, including as the general manager and hospital administrator of the Pengcheng Hospital and Shenzhen Pengai Hospital, as well as chairman and general manager of Shenzhen Pengai Hospital Investment Management Co., Ltd., or Shenzhen Pengai Investment. Dr. Zhou also currently serves as an adjunct professor at the Aesthetic Medical School at Yichun University. In 2012, he was elected as vice-president of the Shenzhen Entrepreneur Association. In 2015, Dr. Zhou was elected as vice-chairman of the First Council of the Internet Aesthetic Medical Subcommittee of Chinese Cosmetic Surgery Association. He is also currently a vice-chairman member of the Fifth Council of the Aesthetic Medical Treatment Subcommittee of the Guangdong Medical Association and vice chairman of the Second Council of the Private Aesthetic Medical Treatment Institution of Chinese Cosmetic Surgery Association. In 2011, Dr. Zhou also participated in the drafting seminar of National Health and Family Planning Commission of the PRC for setting up standards for aesthetic medical treatment institutions. Dr. Zhou obtained an EMBA for hospital administrators from Peking University in October 2005. Dr. Zhou was awarded the "2017 Industry Leader Award" by China Council for the Promotion of International Trade Academy, China Economic Herald and China Business Association (Beijing) Entrepreneur Business Club.
Zhou Pengwu,Aesthetic Medical International Holdings Group Limited创始人之一,Aesthetic Medical International Holdings Group Limited董事会主席兼首席执行官。他自1991年以来一直是一名注册整形外科医生。他拥有30多年的美容医学经验和20多年的美容医院管理经验,从1997年在深圳建立深圳鹏城诊所开始,后来成为鹏城门诊部,然后是深圳鹏城总医院,最后是鹏城医院。他在Aesthetic Medical International Holdings Group Limited担任过各种领导职务,包括鹏城医院和深圳鹏爱医院的总经理和医院行政人员,以及深圳鹏爱医院投资管理有限公司或深圳鹏爱投资的董事长兼总经理。他目前还担任宜春大学美容医学院的兼职教授。2012年当选深圳市企业家协会副会长。2015年当选为中国美容外科协会互联网美容医学分会第一届理事会副主席。现任广东省医学会美容医疗分会第五届理事会副理事长、中国美容外科协会民营美容医疗机构第二届理事会副理事长。2011年参加国家卫生和计划生育委员会关于制定美容医疗机构标准的起草研讨会。他于2005年10月获得北京大学医院管理EMBA学位。被中国国际贸易促进委员会、中国经济导报、中国商业协会(北京)企业家商业俱乐部授予“2017年行业领袖奖”。Zhou博士是Aesthetic Medical International Holdings Group Limited副主席Ding女士的现任配偶,也是Aesthetic Medical International Holdings Group Limited董事Zhou Yitao博士的父亲。
Zhou Pengwu,is one of Aesthetic Medical International Holdings Group Limited founders and is Aesthetic Medical International Holdings Group Limited non-executive co-chairman of the board of directors. Dr. Zhou has been a registered plastic surgeon since 1991. He has over 30 years of experience in aesthetic medicine and over 20 years of experience in managing aesthetic medical hospitals, beginning with the establishment of the Shenzhen Pengcheng Clinic in Shenzhen in 1997, which later became the Pengcheng Outpatient Department, then the Shenzhen Pengcheng General Hospital, and finally the Pengcheng Hospital. He acted in a variety of leadership positions in Aesthetic Medical International Holdings Group Limited company, including as the general manager and hospital administrator of the Pengcheng Hospital and Shenzhen Pengai Hospital, as well as chairman and general manager of Shenzhen Pengai Hospital Investment Management Co., Ltd., or Shenzhen Pengai Investment. Dr. Zhou also currently serves as an adjunct professor at the Aesthetic Medical School at Yichun University. In 2012, he was elected as vice-president of the Shenzhen Entrepreneur Association. In 2015, Dr. Zhou was elected as vice-chairman of the First Council of the Internet Aesthetic Medical Subcommittee of Chinese Cosmetic Surgery Association. He is also currently a vice-chairman member of the Fifth Council of the Aesthetic Medical Treatment Subcommittee of the Guangdong Medical Association and vice chairman of the Second Council of the Private Aesthetic Medical Treatment Institution of Chinese Cosmetic Surgery Association. In 2011, Dr. Zhou also participated in the drafting seminar of National Health and Family Planning Commission of the PRC for setting up standards for aesthetic medical treatment institutions. Dr. Zhou obtained an EMBA for hospital administrators from Peking University in October 2005. Dr. Zhou was awarded the "2017 Industry Leader Award" by China Council for the Promotion of International Trade Academy, China Economic Herald and China Business Association (Beijing) Entrepreneur Business Club.
Zhang Chen

Zhang Chen,著名企业家,曾在不同公司担任多个领导职务,包括担任深圳拉芳投资管理有限公司总经理。目前,Zhang Chen是深圳拉芳投资管理有限公司执行董事,海南润明生物科技有限公司执行董事兼总经理,Hawyu(HK)Limited董事。此外,Zhang Chen于2009年加入中国上市公司拉芳中国有限公司,担任董事、副总经理和董事会秘书,在公司的成功中发挥了关键作用。Zhang Chen是Wu Binhua女士的配偶,Laurena Wu女士和Wu Binqi女士的姐夫(也是董事会成员),以及公司实际控制人Wu guiqian先生的女婿。


Zhang Chen,is currently Aesthetic Medical International Holdings Group Limited executive co-chairman of the board of directors. Mr. Zhang is a renowned entrepreneur, who had held various leadership positions in different companies, including as the general manager of Shenzhen Lafang Investment Management Co., Ltd. Currently, Mr. Zhang is the executive director of Shenzhen Lafang Investment Management Co., Ltd., executive director and general manager of Hainan Runming Biotechnology Co., Ltd., director of Hawyu (HK) Limited. Furthermore, Mr. Zhang joined the Chinese listed company, Lafang China Co., Ltd., in 2009 as a director, vice general manager, and secretary to the board of directors, where he played a crucial role in the company's success. Mr. Zhang is the spouse of Ms. Wu Binhua, the brother-in-law of Ms. Laurena Wu and Ms. Wu Binqi, who are also directors of the Board, and the son-in-law of Mr. Wu Guiqian, the Company's actual controller.
Zhang Chen,著名企业家,曾在不同公司担任多个领导职务,包括担任深圳拉芳投资管理有限公司总经理。目前,Zhang Chen是深圳拉芳投资管理有限公司执行董事,海南润明生物科技有限公司执行董事兼总经理,Hawyu(HK)Limited董事。此外,Zhang Chen于2009年加入中国上市公司拉芳中国有限公司,担任董事、副总经理和董事会秘书,在公司的成功中发挥了关键作用。Zhang Chen是Wu Binhua女士的配偶,Laurena Wu女士和Wu Binqi女士的姐夫(也是董事会成员),以及公司实际控制人Wu guiqian先生的女婿。
Zhang Chen,is currently Aesthetic Medical International Holdings Group Limited executive co-chairman of the board of directors. Mr. Zhang is a renowned entrepreneur, who had held various leadership positions in different companies, including as the general manager of Shenzhen Lafang Investment Management Co., Ltd. Currently, Mr. Zhang is the executive director of Shenzhen Lafang Investment Management Co., Ltd., executive director and general manager of Hainan Runming Biotechnology Co., Ltd., director of Hawyu (HK) Limited. Furthermore, Mr. Zhang joined the Chinese listed company, Lafang China Co., Ltd., in 2009 as a director, vice general manager, and secretary to the board of directors, where he played a crucial role in the company's success. Mr. Zhang is the spouse of Ms. Wu Binhua, the brother-in-law of Ms. Laurena Wu and Ms. Wu Binqi, who are also directors of the Board, and the son-in-law of Mr. Wu Guiqian, the Company's actual controller.
Wu Binhua

Wu Binhua,现任深圳市拉芳投资管理有限公司、深圳市怡景投资有限公司总经理,本康生物医药(深圳)有限公司、拉芳中国(福建)有限公司监事。Wu Binhua女士为新任命的董事会执行联席主席Zhang Chen先生的配偶,Wu Guiqian先生的女儿,Laurena Wu女士和Wu Binqi女士的妹妹。


Wu Binhua,currently serves as a director of Aesthetic Medical International Holdings Group Limited She also serves as the general manager of Shenzhen Lafang Investment Management Co., Ltd. and Shenzhen Yijing Investment Co., Ltd., and a supervisor of Benkang Biopharmaceutical (Shenzhen) Co., Ltd., and Lafang China (Fujian) Co., Ltd. Ms. Wu Binhua is the spouse of Mr. Zhang Chen, the newly appointed executive co-chairman of the Board, and the daughter of Mr. Wu Guiqian and the sister of Ms. Laurena Wu and Ms. Wu Binqi.
Wu Binhua,现任深圳市拉芳投资管理有限公司、深圳市怡景投资有限公司总经理,本康生物医药(深圳)有限公司、拉芳中国(福建)有限公司监事。Wu Binhua女士为新任命的董事会执行联席主席Zhang Chen先生的配偶,Wu Guiqian先生的女儿,Laurena Wu女士和Wu Binqi女士的妹妹。
Wu Binhua,currently serves as a director of Aesthetic Medical International Holdings Group Limited She also serves as the general manager of Shenzhen Lafang Investment Management Co., Ltd. and Shenzhen Yijing Investment Co., Ltd., and a supervisor of Benkang Biopharmaceutical (Shenzhen) Co., Ltd., and Lafang China (Fujian) Co., Ltd. Ms. Wu Binhua is the spouse of Mr. Zhang Chen, the newly appointed executive co-chairman of the Board, and the daughter of Mr. Wu Guiqian and the sister of Ms. Laurena Wu and Ms. Wu Binqi.
Laurena Wu

Laurena Wu,现任Wider Huge Group Limited、澳大利亚万达国际有限公司实际控制人、董事。Laurena Wu女士是Wu Guiqian先生的女儿,也是Wu Binhua女士和Wu Binqi女士的妹妹。


Laurena Wu,currently serves as a director of Aesthetic Medical International Holdings Group Limited She also serves as the actual controller and director of Wider Huge Group Limited and Australia Wanda International Company Limited. Ms. Laurena Wu is the daughter of Mr. Wu Guiqian and the sister of Ms. Wu Binhua and Ms. Wu Binqi.
Laurena Wu,现任Wider Huge Group Limited、澳大利亚万达国际有限公司实际控制人、董事。Laurena Wu女士是Wu Guiqian先生的女儿,也是Wu Binhua女士和Wu Binqi女士的妹妹。
Laurena Wu,currently serves as a director of Aesthetic Medical International Holdings Group Limited She also serves as the actual controller and director of Wider Huge Group Limited and Australia Wanda International Company Limited. Ms. Laurena Wu is the daughter of Mr. Wu Guiqian and the sister of Ms. Wu Binhua and Ms. Wu Binqi.
Wu Binqi

Wu Binqi,现任发松投资管理(上海)有限公司、德威(上海)化妆品有限公司、德威露腾(广州)企业管理有限公司和德基(广州)生命科技有限公司执行董事兼经理,广东益泰投资有限公司监事。吴彬琦女士是一位杰出的企业家,接力中国青年精英协会会员。多年来,她一直在国外学习时尚,现在她把注意力转向了中国的化妆品行业。凭借对国际时尚潮流和设计的深入了解,她准备对这个不断发展的行业产生重大影响。Wu Binqi女士是Wu Guiqian先生的女儿,也是Wu Binhua女士和Laurena Wu女士的妹妹。


Wu Binqi,currently serves as a director of Aesthetic Medical International Holdings Group Limited She also serves as an executive director and the manager of Fasong Investment Management (Shanghai) Co., Ltd., Dewei (Shanghai) Cosmetics Co., Dewei Luteng (Guangzhou) Enterprise Management Co., Ltd. and Deji (Guangzhou) Life Science Technology Co., Ltd., and a supervisor of Guangdong Yitai Investment Co., Ltd. Ms. Wu Binqi is an exceptional entrepreneur and a member of Relay China Youth Elite Association. She has spent years studying fashion abroad and now has turned her attention to the Chinese cosmetics industry. With her deep knowledge of international fashion trends and design, she is poised to make a significant impact on this growing industry. Ms. Wu Binqi is the daughter of Mr. Wu Guiqian and the sister of Ms. Wu Binhua and Ms. Laurena Wu.
Wu Binqi,现任发松投资管理(上海)有限公司、德威(上海)化妆品有限公司、德威露腾(广州)企业管理有限公司和德基(广州)生命科技有限公司执行董事兼经理,广东益泰投资有限公司监事。吴彬琦女士是一位杰出的企业家,接力中国青年精英协会会员。多年来,她一直在国外学习时尚,现在她把注意力转向了中国的化妆品行业。凭借对国际时尚潮流和设计的深入了解,她准备对这个不断发展的行业产生重大影响。Wu Binqi女士是Wu Guiqian先生的女儿,也是Wu Binhua女士和Laurena Wu女士的妹妹。
Wu Binqi,currently serves as a director of Aesthetic Medical International Holdings Group Limited She also serves as an executive director and the manager of Fasong Investment Management (Shanghai) Co., Ltd., Dewei (Shanghai) Cosmetics Co., Dewei Luteng (Guangzhou) Enterprise Management Co., Ltd. and Deji (Guangzhou) Life Science Technology Co., Ltd., and a supervisor of Guangdong Yitai Investment Co., Ltd. Ms. Wu Binqi is an exceptional entrepreneur and a member of Relay China Youth Elite Association. She has spent years studying fashion abroad and now has turned her attention to the Chinese cosmetics industry. With her deep knowledge of international fashion trends and design, she is poised to make a significant impact on this growing industry. Ms. Wu Binqi is the daughter of Mr. Wu Guiqian and the sister of Ms. Wu Binhua and Ms. Laurena Wu.
Zhang Changsuo

Zhang Changsuo是中国幼儿园至十二年级(即“K-12”)教育行业的领军人物,已有超过14年的历史。他专注于K-12和课外培训,为中国西南教育版图的发展做出了重大贡献。Zhang Changsuo先生的教育生涯始于西安新方翔教育科技有限公司的合伙人,凭借专注的方法和创新的思想,他很快成为K-12教育行业的知名专家。2011年,Zhang Changsuo先生创立了明大教育集团(“明大”),并担任创始人和董事长至2021年。在他的领导下,明大成为中国最成功的教育集团之一。明达深耕西南地区K-12市场,为学生提供优质教育和课外培训项目。经过近10年的发展,明大已在中国海南省、福建省、贵州省、广西省设立了39个教学中心,现有在校生3万余人,在职专业教师1000余人。其中,明达在海南省和广西省的市场份额均排名K-12教育行业第一。Zhang Changsuo先生于2003年获得长安大学计算机科学与技术学士学位。


Zhang Changsuo,currently serves as a director of Aesthetic Medical International Holdings Group Limited Mr. Zhang has been a leading figure in the kindergarten through twelfth grade (the "K-12") education industry in China for over 14 years. With a focus on K-12 and extracurricular training, he has made significant contributions to the development of the education landscape in Southwest China. Mr. Zhang Changsuo began his career in education as a partner of Xi'an Xin Fangxiang Education Technology Co., Ltd., where he soon became a prominent expert in the K-12 education industry with his focused approach and innovative ideas. In 2011, Mr. Zhang Changsuo founded Mingda Education Group (the "Mingda") and served as the founder and chairman until 2021. Under his leadership, Mingda became one of the most successful education groups in China. Mingda has deeply cultivated the K-12 market in Southwest China, providing students with high-quality education and extracurricular training programs. After nearly 10 years of development, Mingda has set up a total of 39 teaching centers with more than 30,000 students currently enrolled and over 1,000 professional teachers in service in Hainan Province, Fujian Province, Guizhou Province, and Guangxi Province in China. Among them, Mingda is ranked No.1 in K-12 education industry in terms of market share in Hainan Province and Guangxi Province. Mr. Zhang Changsuo received his bachelor's degree in Computer Science and Technology from Chang'an University in 2003.
Zhang Changsuo是中国幼儿园至十二年级(即“K-12”)教育行业的领军人物,已有超过14年的历史。他专注于K-12和课外培训,为中国西南教育版图的发展做出了重大贡献。Zhang Changsuo先生的教育生涯始于西安新方翔教育科技有限公司的合伙人,凭借专注的方法和创新的思想,他很快成为K-12教育行业的知名专家。2011年,Zhang Changsuo先生创立了明大教育集团(“明大”),并担任创始人和董事长至2021年。在他的领导下,明大成为中国最成功的教育集团之一。明达深耕西南地区K-12市场,为学生提供优质教育和课外培训项目。经过近10年的发展,明大已在中国海南省、福建省、贵州省、广西省设立了39个教学中心,现有在校生3万余人,在职专业教师1000余人。其中,明达在海南省和广西省的市场份额均排名K-12教育行业第一。Zhang Changsuo先生于2003年获得长安大学计算机科学与技术学士学位。
Zhang Changsuo,currently serves as a director of Aesthetic Medical International Holdings Group Limited Mr. Zhang has been a leading figure in the kindergarten through twelfth grade (the "K-12") education industry in China for over 14 years. With a focus on K-12 and extracurricular training, he has made significant contributions to the development of the education landscape in Southwest China. Mr. Zhang Changsuo began his career in education as a partner of Xi'an Xin Fangxiang Education Technology Co., Ltd., where he soon became a prominent expert in the K-12 education industry with his focused approach and innovative ideas. In 2011, Mr. Zhang Changsuo founded Mingda Education Group (the "Mingda") and served as the founder and chairman until 2021. Under his leadership, Mingda became one of the most successful education groups in China. Mingda has deeply cultivated the K-12 market in Southwest China, providing students with high-quality education and extracurricular training programs. After nearly 10 years of development, Mingda has set up a total of 39 teaching centers with more than 30,000 students currently enrolled and over 1,000 professional teachers in service in Hainan Province, Fujian Province, Guizhou Province, and Guangxi Province in China. Among them, Mingda is ranked No.1 in K-12 education industry in terms of market share in Hainan Province and Guangxi Province. Mr. Zhang Changsuo received his bachelor's degree in Computer Science and Technology from Chang'an University in 2003.
Zhou Xichun

Zhou Xichun,自2019年起担任董事长助理,在公司首次公开发行中发挥关键作用。Zhou Xichun先生负责制定拓展非手术美容诊所的业务计划,其中包括资金资源、运营框架、信息技术管理、财务预测等。他的专业知识和领导能力是公司在中国非手术美容医疗市场的先锋角色不可或缺的一部分。Zhou Xichun先生于2021年毕业于加州大学欧文分校,获得经济学学士学位。Zhou Xichun先生是公司创始人Zhou Pengwu博士之子。


Zhou Xichun,currently serves as a director of Aesthetic Medical International Holdings Group Limited Mr. Zhou has served as an assistant to chairman since 2019 and has played a key role in the Company's initial public offering. Mr. Zhou Xichun was responsible for creating the business plan for expanding non-surgical aesthetic medical clinics, which included funding resources, operation framework, information technology management, financial projections and so on. His expertise and leadership have been integral to the Company's pioneer role in the Chinese non-surgical aesthetic medical market. Mr. Zhou Xichun graduated from the University of California, Irvine in 2021 with a bachelor's degree in Economics. Mr. Zhou Xichun is the son of Dr. Zhou Pengwu, the founder of the Company.
Zhou Xichun,自2019年起担任董事长助理,在公司首次公开发行中发挥关键作用。Zhou Xichun先生负责制定拓展非手术美容诊所的业务计划,其中包括资金资源、运营框架、信息技术管理、财务预测等。他的专业知识和领导能力是公司在中国非手术美容医疗市场的先锋角色不可或缺的一部分。Zhou Xichun先生于2021年毕业于加州大学欧文分校,获得经济学学士学位。Zhou Xichun先生是公司创始人Zhou Pengwu博士之子。
Zhou Xichun,currently serves as a director of Aesthetic Medical International Holdings Group Limited Mr. Zhou has served as an assistant to chairman since 2019 and has played a key role in the Company's initial public offering. Mr. Zhou Xichun was responsible for creating the business plan for expanding non-surgical aesthetic medical clinics, which included funding resources, operation framework, information technology management, financial projections and so on. His expertise and leadership have been integral to the Company's pioneer role in the Chinese non-surgical aesthetic medical market. Mr. Zhou Xichun graduated from the University of California, Irvine in 2021 with a bachelor's degree in Economics. Mr. Zhou Xichun is the son of Dr. Zhou Pengwu, the founder of the Company.
Liu Bo

Liu Bo在金融服务领域拥有超过25年的经验,领导ADV在中国的业务。在加入ADV之前,Liu Bo先生曾在私募股权和企业投资领域担任多个高级职位,包括CVC Capital Partners Asia、CITIC Capital和Wanda Investment(不隶属于澳大利亚万达国际有限公司)。Liu Bo先生拥有密歇根大学的MBA学位和金融与经济学学士学位。


Liu Bo,currently serves as a director of Aesthetic Medical International Holdings Group Limited Mr. Liu has over 25 years of experience in the financial services sector and leads ADV's coverage of China. Prior to joining ADV, Mr. Liu Bo served in various senior positions in Private Equity and Corporate investment roles, including CVC Capital Partners Asia, CITIC Capital and Wanda Investment (not affiliated with Australia Wanda International Company Limited). Mr. Liu Bo holds an MBA from the University of Michigan and a Bachelor's in Finance and Economics.
Liu Bo在金融服务领域拥有超过25年的经验,领导ADV在中国的业务。在加入ADV之前,Liu Bo先生曾在私募股权和企业投资领域担任多个高级职位,包括CVC Capital Partners Asia、CITIC Capital和Wanda Investment(不隶属于澳大利亚万达国际有限公司)。Liu Bo先生拥有密歇根大学的MBA学位和金融与经济学学士学位。
Liu Bo,currently serves as a director of Aesthetic Medical International Holdings Group Limited Mr. Liu has over 25 years of experience in the financial services sector and leads ADV's coverage of China. Prior to joining ADV, Mr. Liu Bo served in various senior positions in Private Equity and Corporate investment roles, including CVC Capital Partners Asia, CITIC Capital and Wanda Investment (not affiliated with Australia Wanda International Company Limited). Mr. Liu Bo holds an MBA from the University of Michigan and a Bachelor's in Finance and Economics.
Lin Yingzhou

Lin Yingzhou,从事知识产权实践已有16年。2005年起连续三届担任汕头市专利保护协会副秘书长,现为广东省知识产权专家库专家,汕头市仲裁委员会专家委员、仲裁员,汕头市中级人民法院智库专家。一直为汕头市企业提供专利制度应用、专利维权策略等方面的咨询服务。


Lin Yingzhou,currently serves as an independent director of Aesthetic Medical International Holdings Group Limited Mr. Lin has been engaged in intellectual property practice for 16 years. He has been the deputy secretary general of Shantou Patent Protection Association for three consecutive terms since 2005, and is now an expert of Guangdong Provincial Intellectual Property Expert Pool, an expert member and arbitrator of Shantou Arbitration Commission, and an expert of Shantou Intermediate People's Court Think Tank. He has been providing consulting services to Shantou enterprises on the application of the patent system and the strategy of patent rights defense.
Lin Yingzhou,从事知识产权实践已有16年。2005年起连续三届担任汕头市专利保护协会副秘书长,现为广东省知识产权专家库专家,汕头市仲裁委员会专家委员、仲裁员,汕头市中级人民法院智库专家。一直为汕头市企业提供专利制度应用、专利维权策略等方面的咨询服务。
Lin Yingzhou,currently serves as an independent director of Aesthetic Medical International Holdings Group Limited Mr. Lin has been engaged in intellectual property practice for 16 years. He has been the deputy secretary general of Shantou Patent Protection Association for three consecutive terms since 2005, and is now an expert of Guangdong Provincial Intellectual Property Expert Pool, an expert member and arbitrator of Shantou Arbitration Commission, and an expert of Shantou Intermediate People's Court Think Tank. He has been providing consulting services to Shantou enterprises on the application of the patent system and the strategy of patent rights defense.
Li Yanyun

Li Yanyun,是一位经验丰富的财务专家,在财务和会计、运营和专业服务方面拥有超过20年的经验。她曾在会计、航运、制造业和农业等多个行业工作,获得了这些领域的广泛知识和专门知识。Li Yanyun女士目前担任Fubang Resources(Singapore)Pte Ltd的财务总监,她是特许公认会计师公会会员和新加坡特许会计师。2012年,她在墨尔本皇家理工学院获得金融学硕士学位。


Li Yanyun,currently serves as an independent director of Aesthetic Medical International Holdings Group Limited Ms. Li is a seasoned financial expert with over 20 years of experience in finance and accounting, operation and professional services. She has worked in various industries such as accounting, shipping, manufacturing and agriculture, gaining extensive knowledge and expertise in these fields. Ms. Li Yanyun currently serves as the financial controller of Fubang Resources (Singapore) Pte Ltd. She is a member of the Association of Chartered Certified Accountants and a Chartered Accountant of Singapore. She received her master's degree in Finance from the Royal Melbourne Institute of Technology in 2012.
Li Yanyun,是一位经验丰富的财务专家,在财务和会计、运营和专业服务方面拥有超过20年的经验。她曾在会计、航运、制造业和农业等多个行业工作,获得了这些领域的广泛知识和专门知识。Li Yanyun女士目前担任Fubang Resources(Singapore)Pte Ltd的财务总监,她是特许公认会计师公会会员和新加坡特许会计师。2012年,她在墨尔本皇家理工学院获得金融学硕士学位。
Li Yanyun,currently serves as an independent director of Aesthetic Medical International Holdings Group Limited Ms. Li is a seasoned financial expert with over 20 years of experience in finance and accounting, operation and professional services. She has worked in various industries such as accounting, shipping, manufacturing and agriculture, gaining extensive knowledge and expertise in these fields. Ms. Li Yanyun currently serves as the financial controller of Fubang Resources (Singapore) Pte Ltd. She is a member of the Association of Chartered Certified Accountants and a Chartered Accountant of Singapore. She received her master's degree in Finance from the Royal Melbourne Institute of Technology in 2012.
Xu Tianqing

Xu Tianqing,现任医美国际控股集团有限公司独立董事徐女士在金融服务行业拥有超过5年的本金投资和投资银行业务经验,目前为ADV合作伙伴覆盖大中华区。在加入ADV之前,徐女士在2018年至2021年期间曾在巴克莱银行资本的投资银行部门工作。徐女士拥有加州大学伯克利分校分子与细胞生物学和经济学双学士学位。


Xu Tianqing,currently serves as an independent director of Aesthetic Medical International Holdings Group Limited Ms. Xu has over 5 years of experience in the financial services industry across principal investment and investment banking, currently covering the Greater China Region for ADV Partners. Prior to joining ADV, Ms. Xu worked at Barclays Capital's investment banking division from 2018 to 2021. Ms. Xu holds a dual bachelor's degree in Molecular & Cell Biology and Economics from the University of California, Berkeley.
Xu Tianqing,现任医美国际控股集团有限公司独立董事徐女士在金融服务行业拥有超过5年的本金投资和投资银行业务经验,目前为ADV合作伙伴覆盖大中华区。在加入ADV之前,徐女士在2018年至2021年期间曾在巴克莱银行资本的投资银行部门工作。徐女士拥有加州大学伯克利分校分子与细胞生物学和经济学双学士学位。
Xu Tianqing,currently serves as an independent director of Aesthetic Medical International Holdings Group Limited Ms. Xu has over 5 years of experience in the financial services industry across principal investment and investment banking, currently covering the Greater China Region for ADV Partners. Prior to joining ADV, Ms. Xu worked at Barclays Capital's investment banking division from 2018 to 2021. Ms. Xu holds a dual bachelor's degree in Molecular & Cell Biology and Economics from the University of California, Berkeley.

高管简历

中英对照 |  中文 |  英文
Wu Guanhua

Wu Guanhua,2012年加入Aesthetic Medical International Holdings Group Limited,自2018年8月起担任Aesthetic Medical International Holdings Group Limited首席财务官。Wu Guanhua先生在国际企业会计、运营、财务和战略管理方面拥有超过10年的经验。2006年至2008年,Wu Guanhua先生担任MAZARS(一家全球审计、会计和咨询集团)的项目经理。2008年3月以来,Wu Guanhua先生担任Beijing Junyue Investment Consultancy Co., Ltd.(一家专门为中国中小企业提供融资、上市程序和业务发展战略咨询服务的公司)的合伙人。他于2007年获得the University of Oxford Brooks的理学学士学位。自2007年以来,他是特许公认会计师协会的注册会计师,并于2012年成为会员。


Wu Guanhua,joined Aesthetic Medical International Holdings Group Limited in 2012 and has served as Aesthetic Medical International Holdings Group Limited chief financial officer since August 2018. Mr. Wu Guanhua has over 10 years of experience in international corporate accounting, operations, financial and strategic management. From 2006 to 2008, Mr. Wu Guanhua served as project manager of MAZARS, a global audit, accounting and consulting group. Since March 2008, Mr. Wu Guanhua has served as a partner of Beijing Junyue Investment Consultancy Co., Ltd., a company specializing in consulting services for financing, listing procedures and business development strategies to small and medium enterprise in China. Mr. Wu obtained his bachelor's degree in science from the University of Oxford Brooks in 2007. Mr. Wu is a certified accountant of The Association of Chartered Certified Accountants since 2007 and became a fellow member in 2012.
Wu Guanhua,2012年加入Aesthetic Medical International Holdings Group Limited,自2018年8月起担任Aesthetic Medical International Holdings Group Limited首席财务官。Wu Guanhua先生在国际企业会计、运营、财务和战略管理方面拥有超过10年的经验。2006年至2008年,Wu Guanhua先生担任MAZARS(一家全球审计、会计和咨询集团)的项目经理。2008年3月以来,Wu Guanhua先生担任Beijing Junyue Investment Consultancy Co., Ltd.(一家专门为中国中小企业提供融资、上市程序和业务发展战略咨询服务的公司)的合伙人。他于2007年获得the University of Oxford Brooks的理学学士学位。自2007年以来,他是特许公认会计师协会的注册会计师,并于2012年成为会员。
Wu Guanhua,joined Aesthetic Medical International Holdings Group Limited in 2012 and has served as Aesthetic Medical International Holdings Group Limited chief financial officer since August 2018. Mr. Wu Guanhua has over 10 years of experience in international corporate accounting, operations, financial and strategic management. From 2006 to 2008, Mr. Wu Guanhua served as project manager of MAZARS, a global audit, accounting and consulting group. Since March 2008, Mr. Wu Guanhua has served as a partner of Beijing Junyue Investment Consultancy Co., Ltd., a company specializing in consulting services for financing, listing procedures and business development strategies to small and medium enterprise in China. Mr. Wu obtained his bachelor's degree in science from the University of Oxford Brooks in 2007. Mr. Wu is a certified accountant of The Association of Chartered Certified Accountants since 2007 and became a fellow member in 2012.
Hu Qing

Hu Qing,2012年3月以来,她担任Aesthetic Medical International Holdings Group Limited的董事。她是Aesthetic Medical International Holdings Group Limited首席运营官,主要负责Aesthetic Medical International Holdings Group Limited业务的整体运营。她在医疗行业拥有超过25年的经验。从2004年1月到2005年12月,她担任深圳鹏城总医院副院长。2005年12月至2013年12月,Hu女士连续担任深圳鹏爱医院副院长、总经理。2002年以来,她曾担任深圳鹏爱投资有限公司副总裁、副总经理兼董事。在加入Aesthetic Medical International Holdings Group Limited之前,她在日本工作了13年多,并于1991年4月至2004年3月担任北京中医药大学日本分校的董事和秘书,负责日常运营。她于1983年7月获得华南工程学院(目前称为华南理工大学)无线电工程学士学位,并于2006年8月获得北京大学医院管理人员EMBA学位。


Hu Qing,has served as a director of Aesthetic Medical International Holdings Group Limited since March 2012. She is Aesthetic Medical International Holdings Group Limited chief operating officer, primarily responsible for the overall operations of Aesthetic Medical International Holdings Group Limited business. Ms. Hu has over 25 years of experience in the medical industry. From January 2004 to December 2005, Ms. Hu served as the deputy president of Shenzhen Pengcheng General Hospital. From December 2005 to December 2013, Ms. Hu consecutively served as the deputy hospital administrator, and general manager of Shenzhen Pengai Hospital. Since 2002, Ms. Hu has served as the vice-president, deputy general manager and director of Shenzhen Pengai Investment. Prior to joining Aesthetic Medical International Holdings Group Limited , Ms. Hu spent more than 13 years working in Japan and served as the director and the Secretary for the Beijing University of Traditional Chinese Medicine, Japanese Branch where she was in charge of daily operations, from April 1991 to March 2004. Ms. Hu received her bachelor's degree in radio engineering from the South China Engineering School (currently known as the South China University of Technology) in July 1983 and obtained an EMBA for hospital administrators from Peking University in August 2006.
Hu Qing,2012年3月以来,她担任Aesthetic Medical International Holdings Group Limited的董事。她是Aesthetic Medical International Holdings Group Limited首席运营官,主要负责Aesthetic Medical International Holdings Group Limited业务的整体运营。她在医疗行业拥有超过25年的经验。从2004年1月到2005年12月,她担任深圳鹏城总医院副院长。2005年12月至2013年12月,Hu女士连续担任深圳鹏爱医院副院长、总经理。2002年以来,她曾担任深圳鹏爱投资有限公司副总裁、副总经理兼董事。在加入Aesthetic Medical International Holdings Group Limited之前,她在日本工作了13年多,并于1991年4月至2004年3月担任北京中医药大学日本分校的董事和秘书,负责日常运营。她于1983年7月获得华南工程学院(目前称为华南理工大学)无线电工程学士学位,并于2006年8月获得北京大学医院管理人员EMBA学位。
Hu Qing,has served as a director of Aesthetic Medical International Holdings Group Limited since March 2012. She is Aesthetic Medical International Holdings Group Limited chief operating officer, primarily responsible for the overall operations of Aesthetic Medical International Holdings Group Limited business. Ms. Hu has over 25 years of experience in the medical industry. From January 2004 to December 2005, Ms. Hu served as the deputy president of Shenzhen Pengcheng General Hospital. From December 2005 to December 2013, Ms. Hu consecutively served as the deputy hospital administrator, and general manager of Shenzhen Pengai Hospital. Since 2002, Ms. Hu has served as the vice-president, deputy general manager and director of Shenzhen Pengai Investment. Prior to joining Aesthetic Medical International Holdings Group Limited , Ms. Hu spent more than 13 years working in Japan and served as the director and the Secretary for the Beijing University of Traditional Chinese Medicine, Japanese Branch where she was in charge of daily operations, from April 1991 to March 2004. Ms. Hu received her bachelor's degree in radio engineering from the South China Engineering School (currently known as the South China University of Technology) in July 1983 and obtained an EMBA for hospital administrators from Peking University in August 2006.
Zhang Chen

Zhang Chen,著名企业家,曾在不同公司担任多个领导职务,包括担任深圳拉芳投资管理有限公司总经理。目前,Zhang Chen是深圳拉芳投资管理有限公司执行董事,海南润明生物科技有限公司执行董事兼总经理,Hawyu(HK)Limited董事。此外,Zhang Chen于2009年加入中国上市公司拉芳中国有限公司,担任董事、副总经理和董事会秘书,在公司的成功中发挥了关键作用。Zhang Chen是Wu Binhua女士的配偶,Laurena Wu女士和Wu Binqi女士的姐夫(也是董事会成员),以及公司实际控制人Wu guiqian先生的女婿。


Zhang Chen,is currently Aesthetic Medical International Holdings Group Limited executive co-chairman of the board of directors. Mr. Zhang is a renowned entrepreneur, who had held various leadership positions in different companies, including as the general manager of Shenzhen Lafang Investment Management Co., Ltd. Currently, Mr. Zhang is the executive director of Shenzhen Lafang Investment Management Co., Ltd., executive director and general manager of Hainan Runming Biotechnology Co., Ltd., director of Hawyu (HK) Limited. Furthermore, Mr. Zhang joined the Chinese listed company, Lafang China Co., Ltd., in 2009 as a director, vice general manager, and secretary to the board of directors, where he played a crucial role in the company's success. Mr. Zhang is the spouse of Ms. Wu Binhua, the brother-in-law of Ms. Laurena Wu and Ms. Wu Binqi, who are also directors of the Board, and the son-in-law of Mr. Wu Guiqian, the Company's actual controller.
Zhang Chen,著名企业家,曾在不同公司担任多个领导职务,包括担任深圳拉芳投资管理有限公司总经理。目前,Zhang Chen是深圳拉芳投资管理有限公司执行董事,海南润明生物科技有限公司执行董事兼总经理,Hawyu(HK)Limited董事。此外,Zhang Chen于2009年加入中国上市公司拉芳中国有限公司,担任董事、副总经理和董事会秘书,在公司的成功中发挥了关键作用。Zhang Chen是Wu Binhua女士的配偶,Laurena Wu女士和Wu Binqi女士的姐夫(也是董事会成员),以及公司实际控制人Wu guiqian先生的女婿。
Zhang Chen,is currently Aesthetic Medical International Holdings Group Limited executive co-chairman of the board of directors. Mr. Zhang is a renowned entrepreneur, who had held various leadership positions in different companies, including as the general manager of Shenzhen Lafang Investment Management Co., Ltd. Currently, Mr. Zhang is the executive director of Shenzhen Lafang Investment Management Co., Ltd., executive director and general manager of Hainan Runming Biotechnology Co., Ltd., director of Hawyu (HK) Limited. Furthermore, Mr. Zhang joined the Chinese listed company, Lafang China Co., Ltd., in 2009 as a director, vice general manager, and secretary to the board of directors, where he played a crucial role in the company's success. Mr. Zhang is the spouse of Ms. Wu Binhua, the brother-in-law of Ms. Laurena Wu and Ms. Wu Binqi, who are also directors of the Board, and the son-in-law of Mr. Wu Guiqian, the Company's actual controller.